Document Detail


Prevalence, incidence and persistence of anti-asthma medication use in 2- to 29-year-olds: a nationwide prescription study.
MedLine Citation:
PMID:  19936728     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: The purpose of this study was to examine gender- and age-specific prevalence, incidence, and the type of anti-asthma medications used in the Norwegian population aged 2-29 years during 2005-2007 and to estimate the share of individuals who regularly redeemed medications over a 3-year period. METHODS: We retrieved data from the nationwide Norwegian Prescription Database for all individuals 2-29 years old (n = 1.7 million) who received anti-asthma medications during 2005-2007. Medications included inhaled short- and long-acting beta(2)-agonists, inhaled corticosteroids, fixed-dose combinations of inhaled beta(2)-agonists and corticosteroids, and leukotriene antagonists. RESULTS: In 2007, 5.5% (92,074 individuals) of Norwegians aged 2-29 years received anti-asthma medication, and this figure was stable throughout 2005-2007. Prevalence and incidence were higher among males than females but shifted to female dominance during adolescence. The share of anti-asthma medication users who received inhaled corticosteroids was high in preschool children but decreased by age. Conversely, use of inhaled beta(2)-agonists as monotherapy and of fixed combinations increased with age. Fewer than half the individuals were "persistent" to medication treatment for 3 years by redeeming prescriptions regularly (at least once a year). CONCLUSIONS: In this nationwide study, annual prevalence of anti-asthma medication use was stable during 2005-2007. The gender- and age-specific profile of prevalence and incidence correspond well with other studies. Fewer than half the individuals redeemed prescriptions regularly over 3 years.
Authors:
Oystein Karlstad; Per Nafstad; Aage Tverdal; Svetlana Skurtveit; Kari Furu
Related Documents :
17365198 - Psychogenic cough in an asthmatic child: case report with unusual findings.
11799358 - Childhood asthma: new insights into management.
3742938 - Bronchial cholinergic tone and sensitivity in normal and asthmatic subjects.
16909878 - Asthma in military aviators: safe flying is possible.
14871218 - Sentinel node biopsy in melanoma of the trunk and the extremities in tumescent local an...
22404848 - Qualitative descriptive study exploring schizophrenia and the everyday effect of medica...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-11-21
Journal Detail:
Title:  European journal of clinical pharmacology     Volume:  66     ISSN:  1432-1041     ISO Abbreviation:  Eur. J. Clin. Pharmacol.     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-03-18     Completed Date:  2010-06-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1256165     Medline TA:  Eur J Clin Pharmacol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  399-406     Citation Subset:  IM    
Affiliation:
Norwegian Institute of Public Health, Oslo, Norway. oystein.karlstad@fhi.no
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adrenal Cortex Hormones / therapeutic use*
Asthma / drug therapy*,  epidemiology*
Child
Databases, Factual
Female
Humans
Incidence
Leukotriene Antagonists / therapeutic use*
Male
Prescriptions*
Prevalence
Chemical
Reg. No./Substance:
0/Adrenal Cortex Hormones; 0/Leukotriene Antagonists

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Descriptive study on the efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasm...
Next Document:  Drug utilization and off-label drug use among Spanish emergency room paediatric patients.